spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Regarding the Claim of One-Rial Coverage for Medicine

Regarding the Claim of One-Rial Coverage for Medicine

Public Relations of the Social Security Organization clarified:
The Social Security Organization has neither the authority nor the ability to remove or add medications to the list of drugs covered by insurance.

Pharmaceutical subsidies for certain medications are paid by the government and are not related to insurance organizations.

Insurance providers, including with regard to the medicine mentioned in the video—Therapeutic Multivitamin Capsules—act according to the decisions and regulations of relevant governmental bodies.

The numbers 0, 1, and 2, which appear in the Social Security Organization’s pharmaceutical system, are for internal organizational use only and do not represent a literal one-rial coverage. For medications not covered by basic insurance, but instead supported through the Special and Intractable Diseases Fund or the DaruYar (Medicine Assistance Program), the number 1 is displayed.

The display of number 1 for a medication means that the medicine is eligible for a government subsidy or support from a special fund, not that the basic insurance covers only a negligible amount.

Hot this week

Novo Nordisk Lowers Full-Year Profit Guidance in New CEO’s Maiden Quarter

Wegovy-maker Novo Nordisk lowered its full-year profit forecast on...

Compass Pathways to expedite launch timing of its experimental depression therapy

Drug developer Compass Pathways said on Tuesday it is...

Pharma Investment to establish manufacturing facility at SOHAR Freezone

SOHAR Port and Freezone has signed a land lease...

Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up

Novo Nordisk and Pfizer have revised their bids for...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img